DSpace Repository

CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab

Show simple item record

dc.contributor.author Esposito, FM
dc.contributor.author Lee, J
dc.contributor.author Rha, SY
dc.contributor.author Penkov, KD
dc.contributor.author Moisseev, A
dc.contributor.author Van den Eynde, M
dc.contributor.author Prenen, H
dc.contributor.author Garcia, MD
dc.contributor.author Gumus, M
dc.contributor.author Sagawa, T
dc.contributor.author Nechaeva, M
dc.contributor.author Kajiwara, T
dc.contributor.author Harputluoglu, H
dc.contributor.author Charbonnier, L
dc.contributor.author Bensfia, S
dc.contributor.author Yang, N
dc.contributor.author Oh, DY
dc.date.accessioned 2023-01-02T08:53:06Z
dc.date.available 2023-01-02T08:53:06Z
dc.date.issued 2022
dc.identifier.uri http://hdl.handle.net/11616/86942
dc.source ANNALS OF ONCOLOGY
dc.title CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab
dc.title ravtansine in combination with ramucirumab in pretreated patients with
dc.title gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record